HERON THERAPEUTICS, INC. /DE/ SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
HERON THERAPEUTICS, INC. /DE/ (HRTX) had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $47.87 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2026-08-10
- 2026-06-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $47.87M.
- 2026-03-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $44.64M.
- 2025-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $45.99M.
- 2025-09-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $41.36M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2026-06-30 | $47.87M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $44.64M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $45.99M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $41.36M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $40.05M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $42.48M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $37.42M 10-K · filed 2026-02-26 |
| 2024-09-30 | $34.88M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $37.02M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $38.67M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $36.53M 10-K · filed 2025-02-27 |
| 2023-09-30 | $35.61M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $48.49M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $34.61M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $33.32M 10-K · filed 2024-03-12 |
| 2022-09-30 | $27.82M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $27.88M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $26.39M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $22.56M 10-K · filed 2023-03-29 |
| 2021-09-30 | $24.48M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $24.44M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $20.89M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $24.57M 10-K · filed 2022-02-28 |
| 2020-09-30 | $18.35M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $19.11M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $23.75M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $27.94M 10-K · filed 2021-02-24 |
| 2019-09-30 | $45.04M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $39.63M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $34.06M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $25.50M 10-K · filed 2020-03-02 |
| 2018-09-30 | $18.82M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $12.64M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $12.60M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $9.32M 10-K · filed 2019-02-22 |
| 2017-09-30 | $6.19M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $4.33M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.46M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $342.00K 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |